Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J B Robbins

Showing results (181-190 of 223) with videos related to

Pageof 23
Sort By:
Current Topics in Microbiology and Immunology|January 1, 1989
Prevention of invasive bacterial diseases by immunization with polysaccharide-protein conjugatesJ B Robbins, R Schneerson, S C Szu, et al.
Reviews of Infectious Diseases|March 1, 1991
O-specific side-chain toxin-protein conjugates as parenteral vaccines for the prevention of shigellosis and related diseasesJ B Robbins, C Chu, D C Watson, et al.
Infection and Immunity|May 9, 1998
Synthesis and characterization of lipooligosaccharide-based conjugates as vaccine candidates for Moraxella (Branhamella) catarrhalisX X Gu, J Chen, S J Barenkamp, et al.
Journal of the American Society of Nephrology : JASN|February 1, 1996
Safety and immunogenicity of Staphylococcus aureus type 5 capsular polysaccharide-Pseudomonas aeruginosa recombinant exoprotein A conjugate vaccine in patients on hemodialysisP G Welch, A Fattom, J Moore, et al.
Annali Sclavo. Collana Monografica|January 1, 1986
Results of vaccination in patients with IgA deficiency and/or IgG subclass deficienciesL A Hanson, M A Avanzini, J Björkander, et al.
Lancet (London, England)|November 21, 1987
Protective activity of Vi capsular polysaccharide vaccine against typhoid feverK P Klugman, I T Gilbertson, H J Koornhof, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 1, 1991
Evaluation of monophosphoryl lipid A (MPL) as an adjuvant. Enhancement of the serum antibody response in mice to polysaccharide-protein conjugates by concurrent injection with MPLR Schneerson, A Fattom, S C Szu, et al.
The Journal of Experimental Medicine|December 1, 1985
Escherichia coli K51 and K93 capsular polysaccharides are crossreactive with the group A capsular polysaccharide of Neisseria meningitidis. Immunochemical, biological, and epidemiological studiesN Guirguis, R Schneerson, A Bax, et al.
The New England Journal of Medicine|October 19, 1995
A placebo-controlled trial of a pertussis-toxoid vaccineB Trollfors, J Taranger, T Lagergård, et al.
The Journal of Infectious Diseases|August 1, 1986
Safety and immunogenicity of two Salmonella typhi Vi capsular polysaccharide vaccinesC O Tacket, C Ferreccio, J B Robbins, et al.
Pageof 23

Showing results (181-190 of 223) with videos related to

Sort By:
Pageof 23
Current Topics in Microbiology and Immunology|January 1, 1989
Prevention of invasive bacterial diseases by immunization with polysaccharide-protein conjugatesJ B Robbins, R Schneerson, S C Szu, et al.
Reviews of Infectious Diseases|March 1, 1991
O-specific side-chain toxin-protein conjugates as parenteral vaccines for the prevention of shigellosis and related diseasesJ B Robbins, C Chu, D C Watson, et al.
Infection and Immunity|May 9, 1998
Synthesis and characterization of lipooligosaccharide-based conjugates as vaccine candidates for Moraxella (Branhamella) catarrhalisX X Gu, J Chen, S J Barenkamp, et al.
Journal of the American Society of Nephrology : JASN|February 1, 1996
Safety and immunogenicity of Staphylococcus aureus type 5 capsular polysaccharide-Pseudomonas aeruginosa recombinant exoprotein A conjugate vaccine in patients on hemodialysisP G Welch, A Fattom, J Moore, et al.
Annali Sclavo. Collana Monografica|January 1, 1986
Results of vaccination in patients with IgA deficiency and/or IgG subclass deficienciesL A Hanson, M A Avanzini, J Björkander, et al.
Lancet (London, England)|November 21, 1987
Protective activity of Vi capsular polysaccharide vaccine against typhoid feverK P Klugman, I T Gilbertson, H J Koornhof, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 1, 1991
Evaluation of monophosphoryl lipid A (MPL) as an adjuvant. Enhancement of the serum antibody response in mice to polysaccharide-protein conjugates by concurrent injection with MPLR Schneerson, A Fattom, S C Szu, et al.
The Journal of Experimental Medicine|December 1, 1985
Escherichia coli K51 and K93 capsular polysaccharides are crossreactive with the group A capsular polysaccharide of Neisseria meningitidis. Immunochemical, biological, and epidemiological studiesN Guirguis, R Schneerson, A Bax, et al.
The New England Journal of Medicine|October 19, 1995
A placebo-controlled trial of a pertussis-toxoid vaccineB Trollfors, J Taranger, T Lagergård, et al.
The Journal of Infectious Diseases|August 1, 1986
Safety and immunogenicity of two Salmonella typhi Vi capsular polysaccharide vaccinesC O Tacket, C Ferreccio, J B Robbins, et al.
Pageof 23